From 1999 to 2019, hyperlipidemia-related CVD mortality increased in the United States, with elderly, Black, rural men being most affected.

Glucagon-like peptide 1 receptor agonist use is not associated with an increased risk for thyroid cancer over the short term.

In patients with acute aortic dissection with poor preoperative sleep quality, there is increased risk for adverse clinical outcomes.

Outpatient management of patients with cancer-associated pulmonary embolism (PE) may be a feasible, safe approach with low short-term rates of recurrent venous thromboembolism (VTE), major bleeding, ...

Time-restricted eating may not add additional benefit in visceral adipose tissue reduction over the Mediterranean diet for people with overweight or obesity.

Dexamethasone reduced mortality among patients hospitalized with COVID-19, especially those who were also receiving respiratory support.

Paxlovid may offer marginal benefits for low-risk children with COVID-19; however, among high-risk children with COVID-19, Paxlovid is a safe oral option.

For people with diabetes, the use of GLP-1 RAs is associated with a reduced risk for certain disorders and conditions, including neurocognitive and cardiometabolic disorders, and with an increased ...

The US Department of HHS is awarding the pharmaceutical company Moderna $590 million to continue developing a vaccine to protect against bird flu.

The risk of developing RDS was significantly increased among newborns born to mothers with confirmed COVID-19 infection during pregnancy.

FDA 2025 pulmonology drug alerts, including drug approvals/warnings, vaccine approvals, and medical device recalls/updates.

In asthma, increased inflammation, as measured by the SII, is independently linked to greater mortality risk (all-cause, CV and respiratory).